9QV-31694-55358
4 vaccinations
6 coded responses
52 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 236 / VA
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 1 — Pfizer-BioNTech
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-05
- 2021-03-12
- 2021-03-19
-
2021-03-22
Dose 2 — Pfizer-BioNTech
-
2021-03-22
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Poor · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesFree text: Extremely dizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Hot flush — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Hot flashesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: PainFree text: DizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-06-21
- 2021-09-20
-
2021-10-26
Dose 3 — Pfizer-BioNTech
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Vision blurred — Feeling: Fair · Site: PainFree text: Blurry vision, hard to focus eyesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2022-01-25
- 2022-04-26
-
2022-10-19
Dose 4 — Pfizer-BioNTech
-
2022-10-20
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-21
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitAdult check-in
-
2022-10-21
Report sent to call center — days 1–6 daily, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-10-23
Survey response — days 1–6 daily, dose 4MedDRA: COVID-19 — Feeling: Poor · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I have CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-10-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-25
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-11-30
-
2023-01-18
Survey response — 3 months, dose 4MedDRA: Dizziness, Ear discomfort, Head discomfort, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-18
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech | |
| 3 | 2021-10-26 | Pfizer-BioNTech | No |
| 4 | 2022-10-19 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 6 — day 0, dose 2
Systemic reaction (other): Extremely dizzy
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Hot flashes
Systemic reaction (other): Dizzy
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Blurry vision, hard to focus eyes
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): I have Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Ear discomfort | · | · | ✓ |
| SD | Head discomfort | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | COVID-19 | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
| SRO | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release